KPJ to bear additional costs from IBM Watson solution
Extra costs from cancer care computing solution to be absorbed
KUALA LUMPUR: IBM’s Watson for Oncology for cancer care is now available in Malaysia through KPJ Healthcare Bhd and the hospital group will deploy this cognitive computing solution for its cancer patients at no additional cost to the latter.
The biggest private healthcare provider by bedcount in Malaysia said the additional costs to deploy the Watson for Oncology will be borne by the company.
“Cancer care costs will rise by zero. “We are absorbing the costs for the benefit of the patients and for the benefit of the country in the bigger picture.
“But our hope is that the quality of treatment will be better and the outcome will improve so that people will be cured from cancer,” KPJ president and managing director Datuk Amiruddin Abdul Satar said at a press conference yesterday.
“It will be based on an operating expenditure model, initially we have spent a couple of millions to start it.
“The more we grow the licenses, the more we would have to spend.
“It will depend on the number of doctors using IBM Watson and the number of patients that would require the system: these are based on licenses.
“And it will also depend on the number of activities that are generated through the system,” he added.
Watson for Oncology is a cognitive technology solution developed by IBM in collaboration with US-based Memorial Sloan Kettering Cancer Center (MSK).
It will summarise key medical attributes of a patient and provide information to oncologists to help them deliver cancer treatment options based on training from MSK’s oncologists.
It’s a deal: Chong (right) and Amiruddin shaking hands after the launch of IBM Watson for Oncology to help oncologists in Malaysia provide precision medical care to cancer patients.